




Searching News Database: obesity
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
HSMN NewsFeed - 29 Nov 2022
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
HSMN NewsFeed - 9 May 2022
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
HSMN NewsFeed - 19 Jan 2022
Titan SGS(R) from Standard Bariatrics, Inc. Passes 1,000 Clinical Case Uses
Titan SGS(R) from Standard Bariatrics, Inc. Passes 1,000 Clinical Case Uses
HSMN NewsFeed - 21 Oct 2021
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
HSMN NewsFeed - 21 Jun 2021
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
HSMN NewsFeed - 7 Oct 2019
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
HSMN NewsFeed - 5 Dec 2018
Panther Orthopedics Announces Successful Clinical Use of the PUMA System (TM)
Panther Orthopedics Announces Successful Clinical Use of the PUMA System (TM)
HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
HSMN NewsFeed - 4 Oct 2018
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
HSMN NewsFeed - 4 Sep 2018
Applied Therapeutics Announces Appointment of Riccardo Perfetti, MD, PhD, as Chief Medical Officer
Applied Therapeutics Announces Appointment of Riccardo Perfetti, MD, PhD, as Chief Medical Officer
HSMN NewsFeed - 30 Jul 2018
ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer
ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer
HSMN NewsFeed - 10 May 2018
ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada
ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada
HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
HSMN NewsFeed - 8 Feb 2018
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
HSMN NewsFeed - 24 Jan 2018
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
HSMN NewsFeed - 30 Nov 2017
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
HSMN NewsFeed - 21 Aug 2017
Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
HSMN NewsFeed - 24 May 2017
DERMABOND(R) PRINEO(R) Skin Closure System May Improve Outcomes and Lower Hospital Costs
DERMABOND(R) PRINEO(R) Skin Closure System May Improve Outcomes and Lower Hospital Costs
HSMN NewsFeed - 15 May 2017
BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
HSMN NewsFeed - 20 Apr 2017
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
HSMN NewsFeed - 19 Apr 2017
Ethicon Announces 510(k) Clearance For ECHELON CIRCULAR(TM) Powered Stapler
Ethicon Announces 510(k) Clearance For ECHELON CIRCULAR(TM) Powered Stapler
HSMN NewsFeed - 19 Apr 2017
USGI Medical Appoints Carlos Babini as President and Chief Executive Officer
USGI Medical Appoints Carlos Babini as President and Chief Executive Officer
HSMN NewsFeed - 18 Apr 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
HSMN NewsFeed - 28 Mar 2017
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
HSMN NewsFeed - 17 Jan 2017
Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer
Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer
HSMN NewsFeed - 10 Jan 2017
PENTAX Medical Expands Interventional Endoscopy Offering with Acquisition of C2 Therapeutics
PENTAX Medical Expands Interventional Endoscopy Offering with Acquisition of C2 Therapeutics
HSMN NewsFeed - 14 Dec 2016
Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO
Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO
HSMN NewsFeed - 7 Dec 2016
Gordian Surgical Completes $2.25 Million Raise and Receives FDA Clearance for TroClose1200(TM)
Gordian Surgical Completes $2.25 Million Raise and Receives FDA Clearance for TroClose1200(TM)
HSMN NewsFeed - 27 Sep 2016
EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors
EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors
HSMN NewsFeed - 19 Sep 2016
Medeon Biodesign Receives FDA 510(k) Clearance for Abclose(TM) - Laparoscopic Port Site Closure Device
Medeon Biodesign Receives FDA 510(k) Clearance for Abclose(TM) - Laparoscopic Port Site Closure Device
HSMN NewsFeed - 9 Sep 2016
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
HSMN NewsFeed - 22 Aug 2016
Ethicon Establishes Unmatched Knotless Suture Portfolio With Launch Of STRATAFIX(TM) Spiral Plus Devices
Ethicon Establishes Unmatched Knotless Suture Portfolio With Launch Of STRATAFIX(TM) Spiral Plus Devices
HSMN NewsFeed - 1 Aug 2016
Orexigen Completes Acquisition of All U.S. Rights to Contrave(R) and Launches U.S. Sales Organization
Orexigen Completes Acquisition of All U.S. Rights to Contrave(R) and Launches U.S. Sales Organization
HSMN NewsFeed - 25 Jul 2016
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
HSMN NewsFeed - 26 Jan 2016
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
HSMN NewsFeed - 13 Jan 2016
EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering
EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering
HSMN NewsFeed - 6 Jan 2016
Ivenix, Inc. Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer
Ivenix, Inc. Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer
HSMN NewsFeed - 5 Jan 2016
Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
HSMN NewsFeed - 2 Nov 2015
EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer
EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer
HSMN NewsFeed - 27 May 2015
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
HSMN NewsFeed - 20 Apr 2015
Cardiovascular Systems Receives FDA Clearance for New Peripheral Diamondback Device
Cardiovascular Systems Receives FDA Clearance for New Peripheral Diamondback Device
HSMN NewsFeed - 17 Feb 2015
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
HSMN NewsFeed - 6 May 2014
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
HSMN NewsFeed - 2 Apr 2014
Ablative Solutions Receives FDA Clearance for the Peregrine System(TM) Infusion Catheter
Ablative Solutions Receives FDA Clearance for the Peregrine System(TM) Infusion Catheter
HSMN NewsFeed - 5 Mar 2014
Independent Study Shows V.A.C. VeraFlo(TM) Therapy More Beneficial Than Traditional V.A.C.(R) Therapy
Independent Study Shows V.A.C. VeraFlo(TM) Therapy More Beneficial Than Traditional V.A.C.(R) Therapy
HSMN NewsFeed - 3 Mar 2014
BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine
HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
HSMN NewsFeed - 11 Dec 2013
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
HSMN NewsFeed - 11 Nov 2013
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
HSMN NewsFeed - 29 Oct 2013
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
HSMN NewsFeed - 28 Oct 2013
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
HSMN NewsFeed - 16 Sep 2013
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
HSMN NewsFeed - 17 Jul 2013
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
HSMN NewsFeed - 2 Apr 2013
Apollo Endosurgery's OverStitch(TM) Endoscopic Suturing Platform Launches in Europe
Apollo Endosurgery's OverStitch(TM) Endoscopic Suturing Platform Launches in Europe
HSMN NewsFeed - 6 Mar 2013
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
HSMN NewsFeed - 20 Feb 2013
FDA Approves Natrelle(R) 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
FDA Approves Natrelle(R) 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
HSMN NewsFeed - 14 Feb 2013
Elcelyx Therapeutics Completes $20 Million Series C Financing to Advance NewMet and Lovidia
Elcelyx Therapeutics Completes $20 Million Series C Financing to Advance NewMet and Lovidia
HSMN NewsFeed - 5 Feb 2013
Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
HSMN NewsFeed - 4 Feb 2013
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
HSMN NewsFeed - 27 Nov 2012
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
HSMN NewsFeed - 1 Oct 2012
SafeStitch Medical(R), Inc. Announces Sales of the AMID(TM) Hernia Fixation Device
SafeStitch Medical(R), Inc. Announces Sales of the AMID(TM) Hernia Fixation Device
HSMN NewsFeed - 21 Sep 2012
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
HSMN NewsFeed - 25 Jul 2012
Neurotech(R) Launches Neurotech Recovery - Back, a New Device to Treat Low Back Pain
Neurotech(R) Launches Neurotech Recovery - Back, a New Device to Treat Low Back Pain
HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
HSMN NewsFeed - 16 May 2012
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
HSMN NewsFeed - 2 Apr 2012
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
HSMN NewsFeed - 23 Dec 2011
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
HSMN NewsFeed - 17 Aug 2011
Daiichi Sankyo, Inc. Appoints Executive Vice President of Drug Development for the Americas
Daiichi Sankyo, Inc. Appoints Executive Vice President of Drug Development for the Americas
HSMN NewsFeed - 5 Aug 2011
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
HSMN NewsFeed - 13 Jul 2011
Sequana Medical Receives CE Mark Approval for the ALFApump System and Adds Key Executive to Team
Sequana Medical Receives CE Mark Approval for the ALFApump System and Adds Key Executive to Team
HSMN NewsFeed - 25 May 2011
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
HSMN NewsFeed - 10 May 2011
MR Knee Coil for the Toshiba Vantage Titan Enables Better Clinical Accuracy for Bariatric Imaging
MR Knee Coil for the Toshiba Vantage Titan Enables Better Clinical Accuracy for Bariatric Imaging
HSMN NewsFeed - 25 Apr 2011
NeuroSigma Provides Update on Trigeminal Nerve Stimulation (TNS) - the USB Port to the Brain
NeuroSigma Provides Update on Trigeminal Nerve Stimulation (TNS) - the USB Port to the Brain
HSMN NewsFeed - 11 Apr 2011
Hansen Medical Submits 510(k) Application With U.S. FDA for Vascular Robotic System and Catheter
Hansen Medical Submits 510(k) Application With U.S. FDA for Vascular Robotic System and Catheter
HSMN NewsFeed - 3 Mar 2011
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
HSMN NewsFeed - 17 Feb 2011
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
HSMN NewsFeed - 1 Feb 2011
FDA Issues Complete Response to New Drug Application for Contrave(R) for the Management of Obesity
FDA Issues Complete Response to New Drug Application for Contrave(R) for the Management of Obesity
HSMN NewsFeed - 20 Dec 2010
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
HSMN NewsFeed - 8 Dec 2010
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
HSMN NewsFeed - 1 Dec 2010
Florida Surgeon Completes World’S First Gastric Band with Spider(R) System
Florida Surgeon Completes World’S First Gastric Band with Spider(R) System
HSMN NewsFeed - 10 Nov 2010
Satiety’s TOGA(R) System Named a Top Medical Innovation by Cleveland Clinic Experts
Satiety’s TOGA(R) System Named a Top Medical Innovation by Cleveland Clinic Experts
HSMN NewsFeed - 5 Oct 2010
NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
HSMN NewsFeed - 9 Sep 2010
The Benefits of Crospon's EndoFLIP(R) System Presented at International Obesity Surgery Congress 2010
The Benefits of Crospon's EndoFLIP(R) System Presented at International Obesity Surgery Congress 2010
HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
HSMN NewsFeed - 1 Jul 2010
Eisai Inc. Enters Marketing and Supply Agreement with Arena Pharmaceuticals for Lorcaserin
Eisai Inc. Enters Marketing and Supply Agreement with Arena Pharmaceuticals for Lorcaserin
HSMN NewsFeed - 1 Jun 2010
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
HSMN NewsFeed - 18 May 2010
IDEV Technologies Announces European Launch of SUPERA VERITAS(TM) Stent Delivery System
IDEV Technologies Announces European Launch of SUPERA VERITAS(TM) Stent Delivery System
HSMN NewsFeed - 3 May 2010
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 23 Apr 2010
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
HSMN NewsFeed - 22 Apr 2010
Outcomes of Patients Dismissed from the Hospital with Noncardiac Chest Pain
Outcomes of Patients Dismissed from the Hospital with Noncardiac Chest Pain
HSMN NewsFeed - 26 Mar 2010
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity
HSMN NewsFeed - 18 Mar 2010
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
HSMN NewsFeed - 17 Mar 2010
Caron D'Ambruso Joins SafeStitch as Vice President of Sales and Marketing
Caron D'Ambruso Joins SafeStitch as Vice President of Sales and Marketing
HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
HSMN NewsFeed - 8 Mar 2010
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
HSMN NewsFeed - 2 Mar 2010
OSI Pharmaceuticals Board of Directors to Review Astellas' Unsolicited Tender Offer
OSI Pharmaceuticals Board of Directors to Review Astellas' Unsolicited Tender Offer
HSMN NewsFeed - 1 Mar 2010
OSI Pharmaceuticals Confirms Receipt of Unsolicited Proposal From Astellas Pharma
OSI Pharmaceuticals Confirms Receipt of Unsolicited Proposal From Astellas Pharma
HSMN NewsFeed - 1 Mar 2010
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
HSMN NewsFeed - 22 Feb 2010
EnteroMedics Appoints Dr. Scott Shikora as Consulting Chief Medical Officer
EnteroMedics Appoints Dr. Scott Shikora as Consulting Chief Medical Officer
HSMN NewsFeed - 11 Feb 2010
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16
HSMN NewsFeed - 11 Feb 2010
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
HSMN NewsFeed - 10 Feb 2010
Boston Scientific Announces Management Changes and Restructuring Initiatives
Boston Scientific Announces Management Changes and Restructuring Initiatives
HSMN NewsFeed - 2 Feb 2010
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
HSMN NewsFeed - 18 Jan 2010
Covidien and Allergan Extend Agreement to Promote LAP-BAND(R) Adjustable Gastric Banding System
Covidien and Allergan Extend Agreement to Promote LAP-BAND(R) Adjustable Gastric Banding System
HSMN NewsFeed - 13 Jan 2010
The Foundry Announces Completion of Series A Financing for Twelfth Company
The Foundry Announces Completion of Series A Financing for Twelfth Company
HSMN NewsFeed - 29 Dec 2009
VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
HSMN NewsFeed - 2 Nov 2009
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
HSMN NewsFeed - 21 Oct 2009
NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
HSMN NewsFeed - 14 Sep 2009
InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer
InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer
HSMN NewsFeed - 1 Sep 2009
Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis' President, CEO & CSO
Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis' President, CEO & CSO
HSMN NewsFeed - 19 Jun 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
HSMN NewsFeed - 7 May 2009
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
HSMN NewsFeed - 23 Mar 2009
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
HSMN NewsFeed - 20 Feb 2009
Surgeons Perform First Incisionless Bariatric Procedure in the United States
Surgeons Perform First Incisionless Bariatric Procedure in the United States
HSMN NewsFeed - 17 Feb 2009
SafeStitch Medical, Inc. Announces FDA Approval to Market Its SMART Dilator(TM)
SafeStitch Medical, Inc. Announces FDA Approval to Market Its SMART Dilator(TM)
HSMN NewsFeed - 5 Dec 2008
Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
HSMN NewsFeed - 27 Nov 2008
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
HSMN NewsFeed - 5 Nov 2008
Akesis Pharmaceuticals Appoints Carl LeBel as CEO and Jay Lichter as Executive Chairman
Akesis Pharmaceuticals Appoints Carl LeBel as CEO and Jay Lichter as Executive Chairman
HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
HSMN NewsFeed - 8 Oct 2008
Brennen Medical, LLC Launches XenMatriX(R) for Abdominal Wall (Hernia) Repair
Brennen Medical, LLC Launches XenMatriX(R) for Abdominal Wall (Hernia) Repair
HSMN NewsFeed - 2 Oct 2008
Apollo Endosurgery Announces 510(k) Clearance for Its Flexible Endoscopic Suturing System
Apollo Endosurgery Announces 510(k) Clearance for Its Flexible Endoscopic Suturing System
HSMN NewsFeed - 5 Sep 2008
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
HSMN NewsFeed - 2 Sep 2008
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
HSMN NewsFeed - 22 Jul 2008
Response Biomedical Receives US FDA Clearance for RAMP(R) NT-proBNP Test for Diagnosis of Heart Failure
Response Biomedical Receives US FDA Clearance for RAMP(R) NT-proBNP Test for Diagnosis of Heart Failure
HSMN NewsFeed - 2 Jul 2008
Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
HSMN NewsFeed - 30 Jun 2008
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer
HSMN NewsFeed - 11 Jun 2008
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
HSMN NewsFeed - 11 Jun 2008
Sorin Group Announces Divestiture of Its Peripheral Stent Business to Datascope
Sorin Group Announces Divestiture of Its Peripheral Stent Business to Datascope
HSMN NewsFeed - 9 Jun 2008
Cook Medical Announces FDA 510(k) Clearance of Evolution(R) Controlled Release Esophageal Stent System
Cook Medical Announces FDA 510(k) Clearance of Evolution(R) Controlled Release Esophageal Stent System
HSMN NewsFeed - 12 Mar 2008
Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
HSMN NewsFeed - 10 Mar 2008
OREXIGEN(TM) Therapeutics Appoints Carol Baum as Vice President of Commercialization
OREXIGEN(TM) Therapeutics Appoints Carol Baum as Vice President of Commercialization
HSMN NewsFeed - 12 Feb 2008
Sapphire Therapeutics Promotes Suzan Allen to Vice President Clinical Operations
Sapphire Therapeutics Promotes Suzan Allen to Vice President Clinical Operations
HSMN NewsFeed - 12 Feb 2008
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
HSMN NewsFeed - 11 Feb 2008
Cook Medical Introduces Umbilical Hernia Graft Designed to Fit Individual Patient Anatomies
Cook Medical Introduces Umbilical Hernia Graft Designed to Fit Individual Patient Anatomies
HSMN NewsFeed - 31 Jan 2008
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
HSMN NewsFeed - 28 Jan 2008
Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
HSMN NewsFeed - 16 Jan 2008
VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
HSMN NewsFeed - 7 Jan 2008
EnteroMedics(TM) Announces Pivotal Clinical Study of its VBLOC(TM) Therapy for Obesity
EnteroMedics(TM) Announces Pivotal Clinical Study of its VBLOC(TM) Therapy for Obesity
HSMN NewsFeed - 21 Dec 2007
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
HSMN NewsFeed - 20 Dec 2007
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
HSMN NewsFeed - 14 Dec 2007
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
HSMN NewsFeed - 13 Dec 2007
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
HSMN NewsFeed - 11 Dec 2007
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
HSMN NewsFeed - 11 Dec 2007
OREXIGEN(TM) Therapeutics Initiates Fourth Phase III Trial for Contrave(TM) to Treat Obesity
OREXIGEN(TM) Therapeutics Initiates Fourth Phase III Trial for Contrave(TM) to Treat Obesity
HSMN NewsFeed - 8 Nov 2007
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
HSMN NewsFeed - 8 Nov 2007
Neurochem announces important initiatives to provide medical and health benefits to patients
Neurochem announces important initiatives to provide medical and health benefits to patients
HSMN NewsFeed - 29 Oct 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
HSMN NewsFeed - 25 Oct 2007
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
Elixir Pharmaceuticals Names Paul M. Martha, M.D. as Chief Medical Officer
HSMN NewsFeed - 17 Oct 2007
OREXIGEN(TM) Therapeutics Initiates its Third Phase III Trial for Contrave(TM) to Treat Obesity
OREXIGEN(TM) Therapeutics Initiates its Third Phase III Trial for Contrave(TM) to Treat Obesity
Additional items found! 463

Members Archive contains
463 additional stories matching:
obesity
(Password required)
obesity
(Password required)